Upper Limb Spasticity Post-Stroke Clinical Trial
Official title:
Cost Determination Study For Different Botulinum Toxin A Preparations In The Treatment Of Upper Limb Spasticity Post-Stroke In Portugal
This study aims to estimate the costs of botulinum toxin A utilization in standard practice
for the treatment of upper limb spasticity post-stroke in Portugal.
It will consider the three most used locally available brands of botulinum toxin A which show
similar efficacy and safety profiles thus making it relevant to understand if choosing
between one or another brand can depend directly on economic factors.
The study will estimate direct and indirect drug-associated costs as determinant variables
for the price of each drug and the standard drug dose used in clinical practice.
A comparison will be performed between direct costs associated with each therapeutic strategy and cost analysis assuming that quality of life values may be different between patients treated with each treatment. ;